Collegium Pharmaceutical ... (COLL)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
32.80
-0.38 (-1.15%)
At close: Jan 15, 2025, 9:30 AM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Cash & Equivalents | 238.95M | 173.69M | 186.43M | 174.12M | 170.02M | 146.63M | 118.70M | 153.22M | 95.70M | 1.63M | 7.55M |
Short-Term Investments | 71.60M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 2.55M | 2.55M | 2.55M | n/a | n/a | 97.00K | 97.00K | 97.00K | n/a | n/a |
Other Long-Term Assets | 1.87M | 100.00K | 87.00K | 2.67M | 178.00K | 204.00K | 161.00K | 301.00K | n/a | 80.00K | 80.00K |
Receivables | 179.53M | 183.12M | 105.84M | 83.32M | 72.95M | 77.95M | 9.97M | 2.13M | n/a | n/a | n/a |
Inventory | 32.33M | 46.50M | 17.39M | 15.61M | 9.64M | 7.82M | 1.81M | 1.32M | n/a | n/a | n/a |
Other Current Assets | 15.20M | 16.68M | 5.88M | 4.84M | 3.10M | 5.12M | 3.00M | 1.91M | 1.19M | 2.86M | 710.00K |
Total Current Assets | 537.60M | 419.99M | 315.54M | 277.89M | 255.72M | 237.51M | 133.48M | 158.57M | 96.88M | 4.50M | 8.26M |
Property-Plant & Equipment | 22.01M | 26.38M | 27.14M | 27.38M | 20.90M | 9.27M | 1.83M | 1.04M | 738.00K | 514.00K | 693.00K |
Goodwill & Intangibles | 555.57M | 701.16M | 268.72M | 335.90M | 29.50M | 44.26M | n/a | 2.10M | n/a | n/a | n/a |
Total Long-Term Assets | 605.71M | 754.14M | 376.53M | 365.95M | 50.58M | 53.73M | 2.08M | 3.44M | 835.00K | 594.00K | 773.00K |
Total Assets | 1.14B | 1.17B | 692.08M | 643.84M | 306.30M | 291.25M | 135.57M | 162.02M | 97.72M | 5.09M | 9.03M |
Account Payables | 8.69M | 3.49M | 4.19M | 10.02M | 6.25M | 12.15M | 5.68M | 9.11M | 3.54M | 2.21M | 1.22M |
Deferred Revenue | 988.00K | n/a | n/a | n/a | n/a | n/a | n/a | 4.94M | -9.55M | n/a | n/a |
Short-Term Debt | 184.32M | 164.72M | 49.98M | 48.95M | 5.14M | 1.64M | 1.48M | 2.67M | 2.67M | 6.19M | 333.00K |
Other Current Liabilities | 256.76M | 261.16M | 222.20M | 178.66M | 190.37M | 175.33M | 24.32M | 8.88M | 2.23M | 2.02M | 1.07M |
Total Current Liabilities | 457.92M | 270.11M | 230.40M | 191.23M | 197.28M | 187.48M | 31.49M | 22.93M | 5.76M | 10.42M | 2.62M |
Long-Term Debt | 489.96M | 545.56M | 209.58M | 218.36M | 17.11M | 9.86M | n/a | 1.51M | 4.21M | 6.91M | 775.00K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 676.00K | n/a | n/a | n/a | n/a | 59.00K |
Total Long-Term Liabilities | 489.96M | 709.17M | 258.75M | 266.58M | 21.59M | 12.18M | 7.16M | 4.18M | 6.88M | 6.91M | 834.00K |
Total Liabilities | 947.88M | 979.29M | 489.15M | 457.81M | 218.87M | 199.66M | 31.49M | 27.11M | 12.65M | 17.33M | 3.45M |
Total Debt | 674.28M | 872.79M | 258.75M | 266.58M | 21.59M | 11.50M | 1.48M | 4.15M | 6.81M | 13.01M | 973.00K |
Common Stock | 38.00K | 37.00K | 36.00K | 35.00K | 34.00K | 33.00K | 33.00K | 29.00K | 21.00K | 8.00K | 1K |
Retained Earnings | -233.19M | -281.34M | -256.34M | -333.15M | -359.90M | -337.18M | -298.05M | -223.18M | -129.01M | -101.75M | -80.54M |
Comprehensive Income | 14.00K | 0.00 | -0.00 | -0.00 | n/a | n/a | -1.67M | -1.33M | -1.07M | -903.00K | -716.00K |
Shareholders Equity | 195.43M | 194.84M | 202.93M | 186.03M | 87.43M | 91.58M | 104.08M | 134.91M | 85.07M | -12.24M | 5.58M |
Total Investments | 71.60M | 2.55M | 2.55M | 2.55M | n/a | n/a | 97.00K | 97.00K | 97.00K | n/a | n/a |